1. Attendees will be able to explain the rationale behind the current recommendations regarding oxytocin dosing during the third stage

2. Attendees will be able to weigh risks and benefits of tranexaminc acid adminstration during postpartum hemorrhage

Session date: 
11/17/2017 - 8:15am to 9:15am CST
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Barbara Scavone, MD